US Map / Oklahoma
State OK

Clinical Trials in Oklahoma

Recruiting clinical trials with at least one study location in Oklahoma. Data updated daily from ClinicalTrials.gov.

Total Trials
132
Recruiting Now
132
← Back to US Map
Top Conditions in Oklahoma
Stage IVB Prostate Cancer AJCC v8 (4)Colorectal Cancer (4)Systemic Lupus Erythematosus (3)Asthma (3)Prostate Cancer (3)Ovarian Cancer (3)Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)Stage II Lip and Oral Cavity Cancer AJCC v8 (2)Stage IV Lung Cancer AJCC v8 (2)Chronic Lymphocytic Leukemia (2)Cardiovascular Diseases (2)

Frequently Asked Questions — Clinical Trials in Oklahoma

How many clinical trials are currently recruiting in Oklahoma?
ClinicalMetric currently tracks 132 actively recruiting clinical trials with at least one location in Oklahoma. The total number of registered studies—including active but not currently enrolling trials—is 132. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Oklahoma?
Oklahoma hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Colorectal Cancer, Systemic Lupus Erythematosus, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Oklahoma serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Oklahoma?
To join a clinical trial in Oklahoma, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Oklahoma maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Oklahoma

NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
View Trial →
NCT06227377 Phase 1
Recruiting
QTX3034 in Patients With KRAS G12D Mutation
Condition
Solid Tumors
Enrollment
250 pts
Location
United States
Sponsor
Quanta Therapeutics
View Trial →
NCT06828159 N/A
Recruiting
Dietary Wild Blueberries and Joint Health
Condition
Gut -Microbiota
Enrollment
50 pts
Location
United States
Sponsor
University of Nevada, Las Vega
View Trial →
NCT06532279 Phase 2
Recruiting
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the ...
Condition
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
98 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT06421558 N/A
Recruiting
Impact of Direct Current Electrical Stimulation on Treatment of Lumbosacral Radi...
Condition
Radiculopathy Lumbar
Enrollment
150 pts
Location
United States
Sponsor
NeuFit - Neurological Fitness
View Trial →
NCT04661358 Phase 3
Recruiting
Fenofibrate for Prevention of DR Worsening
Condition
Diabetic Retinopathy
Enrollment
560 pts
Location
United States
Sponsor
Jaeb Center for Health Researc
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06100289 Phase 3
Recruiting
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Croh...
Condition
Ulcerative Colitis
Enrollment
70 pts
Location
United States, Belgium, Bulgaria
Sponsor
Takeda
View Trial →
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07220460 Phase 2
Recruiting
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With D...
Condition
Bipolar I or II Disorder
Enrollment
200 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06967805 Phase 2
Recruiting
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis...
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
164 pts
Location
United States, Argentina, Australia
Sponsor
Mediar Therapeutics
View Trial →
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
View Trial →
NCT05256641 Phase 1, Phase 2
Recruiting
Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lympho...
Condition
Diffuse Large B-Cell Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
View Trial →
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
View Trial →
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT04879329 Phase 2
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer Th...
Condition
Urothelial Carcinoma
Enrollment
372 pts
Location
United States, Argentina, Australia
Sponsor
Seagen, a wholly owned subsidi
View Trial →
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT06480383 Phase 2
Recruiting
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiet...
Condition
Generalized Anxiety Disorder
Enrollment
705 pts
Location
United States, Bulgaria, Czechia
Sponsor
Intra-Cellular Therapies, Inc.
View Trial →
NCT06543576 Phase 1, Phase 2
Recruiting
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunoth...
Condition
Cervical Adenocarcinoma
Enrollment
35 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
View Trial →
NCT07215624 N/A
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Netw...
Condition
Malignant Digestive System Neoplasm
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT06701682 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilob...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
View Trial →
NCT04647227 Phase 4
Recruiting
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Condition
Hemophilia A With Inhibitor
Enrollment
55 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT05111977 N/A
Recruiting
Gastrointestinal Interoception in Anorexia Nervosa
Condition
Anorexia Nervosa
Enrollment
150 pts
Location
United States
Sponsor
Laureate Institute for Brain R
View Trial →
NCT00198068 N/A
Recruiting
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiph...
Condition
Systemic Lupus Erythematosus
Enrollment
700 pts
Location
United States, Canada, United Kingdom
Sponsor
Hospital for Special Surgery,
View Trial →
Page 1 of 6 — 132 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology